Mesalazine Regulates <i>DUSP1</i>, <i>DUSP4</i>, and <i>DUSP5</i> Expression in Colorectal Cancer: In Vitro and Bioinformatic Evidence.
- DOI
- 10.3390/pharmaceutics18010029
- Published
- 2025-12-25
- Container
- Pharmaceutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics18010029,
title = {Mesalazine Regulates <i>DUSP1</i>, <i>DUSP4</i>, and <i>DUSP5</i> Expression in Colorectal Cancer: In Vitro and Bioinformatic Evidence.},
author = {Madej M and Nowak I and Strzałka-Mrozik B and Kimsa-Dudek M and Kruszniewska-Rajs C and Gola JM.},
year = {2025},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics18010029},
url = {https://doi.org/10.3390/pharmaceutics18010029}
}RIS
TY - JOUR TI - Mesalazine Regulates <i>DUSP1</i>, <i>DUSP4</i>, and <i>DUSP5</i> Expression in Colorectal Cancer: In Vitro and Bioinformatic Evidence. AU - Madej M AU - Nowak I AU - Strzałka-Mrozik B AU - Kimsa-Dudek M AU - Kruszniewska-Rajs C AU - Gola JM. PY - 2025 JO - Pharmaceutics DO - 10.3390/pharmaceutics18010029 UR - https://doi.org/10.3390/pharmaceutics18010029 ER -
APA
M, M., I, N., B, S., M, K., C, K., & JM., G. (2025). Mesalazine Regulates <i>DUSP1</i>, <i>DUSP4</i>, and <i>DUSP5</i> Expression in Colorectal Cancer: In Vitro and Bioinformatic Evidence.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18010029
Source records
- europe-pmc · retrieved 2026-11-10T19:56:25.572Z
- doaj · retrieved 2026-11-10T19:56:25.567Z